Reference Population for Speckle Tracking Imaging

Inclusion Criteria: * Be between the ages of 20 - 80 years at study entry * Provide written informed consent and be able to comply with study procedures, including permission to access medical records * Have a BMI index equal to or less than 35 * Less than 5% risk of developing coronary artery disease as determined using the Combined Diamond/Forrester and CASS data (ACC Stable CAD Guidelines) Exclusion Criteria: * Have taken cardioactive drugs within 6 months prior to examination * These include but are not limited to beta-blockers, calcium channel blockers, and angiotensin converting enzyme inhibitors * Currently clinically significant chronic or acute illness * Documented cardiovascular disease * Possess abnormal cardiac structure and function after examination with routine ECHO * This may include valvular defects, left ventricular hypertrophy, cardiomyopathies or pericardial disease * Documented congenital heart conditions or defects * History of diabetes * Be unwilling to provide voluntary consent